{"abstract":"The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled \"Annual Status Report Information and Other Submissions for Postmarketing Requirements and Commitments: Using Forms FDA 3988 and FDA 3989.\" Forms FDA 3988, Transmittal of PMR/PMC Submissions for Drugs and Biologics, and FDA 3989, PMR/PMC Annual Status Report for Drugs and Biologics, are intended to facilitate submissions by drug and biological product application holders of complete and accurate information on postmarketing requirements (PMRs) and postmarketing commitments (PMCs) in a consistent format. These forms are expected to result in improved accuracy and timeliness of FDA's identification and review of those submissions containing information on PMRs and PMCs. This guidance covers the purpose of each form, when to use these forms, and how to submit these forms. The guidance also explains where applicants will be able to find the forms and instructions. This guidance finalizes the draft guidance of the same name issued on October 21, 2020.","action":"Notice of availability.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2023/09/15/2023-20014.html","cfr_references":[],"citation":"88 FR 63580","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"The announcement of the guidance is published in the Federal Register on September 15, 2023.","disposition_notes":null,"docket_ids":["Docket No. FDA-2018-N-3771"],"dockets":[{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2023-09-15","updated_at":"2023-09-15T09:56:58.296-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2018-N-3771-0009","allow_late_comments":null,"id":"FDA-2018-N-3771-0009","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2018-N-3771","title":"Report on the Performance of Drug and Biologics Firms in Conducting Postmarketing Requirements and Commitments; Availability"}],"document_number":"2023-20014","effective_on":null,"end_page":63582,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2023/09/15/2023-20014.xml","html_url":"https://www.federalregister.gov/documents/2023/09/15/2023-20014/annual-status-report-information-and-other-submissions-for-postmarketing-requirements-and","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2023-20014?publication_date=2023-09-15","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2023-09-15/2023-20014/mods.xml","not_received_for_publication":null,"page_length":3,"page_views":{"count":809,"last_updated":"2026-09-23 04:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2023-09-15/pdf/2023-20014.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2023-20014.pdf?1694695618","publication_date":"2023-09-15","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2023/09/15/2023-20014.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":0,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2018-N-3771","supporting_documents_count":0,"docket_id":"FDA-2018-N-3771","document_id":"FDA-2018-N-3771-0009","regulation_id_number":null,"title":"Report on the Performance of Drug and Biologics Firms in Conducting Postmarketing Requirements and Commitments; Availability","checked_regulationsdotgov_at":"2023-09-16T13:00:08Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":63580,"subtype":null,"title":"Annual Status Report Information and Other Submissions for Postmarketing Requirements and Commitments: Using Forms FDA 3988 and FDA 3989; Guidance for Industry; Availability","toc_doc":"Annual Status Report Information and Other Submissions for Postmarketing Requirements and Commitments","toc_subject":"Guidance:\n","topics":[],"type":"Notice","volume":88}